APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antiemetics

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Antiemetics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026189 pages

Choose your research edition.

Industry ResearchAntiemetics Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Antiemetics Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Antiemetics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antiemetics Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Antiemetics Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Antiemetics market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Antiemetics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antiemetics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antiemetics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Antiemetics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antiemetics include Johnson & Johnson, Merck, Eli Lilly, Pfizer, GlaxoSmithKline, Baxter, Sanofi Aventis, Bristol Myers Squibb and Astellas, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Antiemetics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antiemetics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antiemetics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antiemetics market size, projected growth trends, production technologies, key applications, and end-use industries.

Antiemetics Segment by Company

Johnson & Johnson

Merck

Eli Lilly

Pfizer

GlaxoSmithKline

Baxter

Sanofi Aventis

Bristol Myers Squibb

Astellas

Antiemetics Segment by Type

Steroids

Antihistamines (H1 histamine receptor antagonists)

Anticholinergics

Dopamine antagonists

Cannabinoids

Benzodiazepines

NK1 receptor antagonist

5-HT3 receptor antagonists

Others

Antiemetics Segment by Application

Retail Pharmacy

Online Pharmacy

Hospital Pharmacy

Others

Antiemetics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antiemetics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antiemetics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antiemetics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antiemetics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antiemetics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Antiemetics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Antiemetics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Antiemetics Industry Trends Table 2. Antiemetics Industry Drivers Table 3. Antiemetics Industry Opportunities and Challenges Table 4. Antiemetics Industry Restraints Table 5. Global Antiemetics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Antiemetics Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Antiemetics Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Antiemetics Sales Market Share by Manufacturers Table 9. Global Antiemetics Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Antiemetics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Antiemetics Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Antiemetics Manufacturers, Product Type & Application Table 13. Global Antiemetics Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Antiemetics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Steroids Table 17. Major Manufacturers of Antihistamines (H1 histamine receptor antagonists) Table 18. Major Manufacturers of Anticholinergics Table 19. Major Manufacturers of Dopamine antagonists Table 20. Major Manufacturers of Cannabinoids Table 21. Major Manufacturers of Benzodiazepines Table 22. Major Manufacturers of NK1 receptor antagonist Table 23. Major Manufacturers of 5-HT3 receptor antagonists Table 24. Major Manufacturers of Others Table 25. Global Antiemetics Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Antiemetics Sales by Type (2021-2026) & (K Units) Table 27. Global Antiemetics Sales by Type (2027-2032) & (K Units) Table 28. Global Antiemetics Sales Market Share by Type (2021-2026) Table 29. Global Antiemetics Sales Market Share by Type (2027-2032) Table 30. Global Antiemetics Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 31. Global Antiemetics Revenue by Type (2021-2026) & (K Units) Table 32. Global Antiemetics Revenue by Type (2027-2032) & (K Units) Table 33. Global Antiemetics Revenue Market Share by Type (2021-2026) Table 34. Global Antiemetics Revenue Market Share by Type (2027-2032) Table 35. Major Manufacturers of Retail Pharmacy Table 36. Major Manufacturers of Online Pharmacy Table 37. Major Manufacturers of Hospital Pharmacy Table 38. Major Manufacturers of Others Table 39. Global Antiemetics Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Antiemetics Sales by Application (2021-2026) & (K Units) Table 41. Global Antiemetics Sales by Application (2027-2032) & (K Units) Table 42. Global Antiemetics Sales Market Share by Application (2021-2026) Table 43. Global Antiemetics Sales Market Share by Application (2027-2032) Table 44. Global Antiemetics Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 45. Global Antiemetics Revenue by Application (2021-2026) & (K Units) Table 46. Global Antiemetics Revenue by Application (2027-2032) & (K Units) Table 47. Global Antiemetics Revenue Market Share by Application (2021-2026) Table 48. Global Antiemetics Revenue Market Share by Application (2027-2032) Table 49. Global Antiemetics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 50. Global Antiemetics Sales by Region (2021-2026) & (K Units) Table 51. Global Antiemetics Sales Market Share by Region (2021-2026) Table 52. Global Antiemetics Sales Forecasted by Region (2027-2032) & (K Units) Table 53. Global Antiemetics Sales Forecasted Market Share by Region (2027-2032) Table 54. North America Antiemetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. North America Antiemetics Sales by Country (2021-2026) & (K Units) Table 56. North America Antiemetics Sales by Country (2027-2032) & (K Units) Table 57. Europe Antiemetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Europe Antiemetics Sales by Country (2021-2026) & (K Units) Table 59. Europe Antiemetics Sales by Country (2027-2032) & (K Units) Table 60. Asia Pacific Antiemetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 61. Asia Pacific Antiemetics Sales by Country (2021-2026) & (K Units) Table 62. Asia Pacific Antiemetics Sales by Country (2027-2032) & (K Units) Table 63. South America, Middle East and Africa Antiemetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 64. South America, Middle East and Africa Antiemetics Sales by Country (2021-2026) & (K Units) Table 65. South America, Middle East and Africa Antiemetics Sales by Country (2027-2032) & (K Units) Table 66. Global Antiemetics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 67. Global Antiemetics Revenue by Region (2021-2026) & (US$ Million) Table 68. Global Antiemetics Revenue by Region (2027-2032) & (US$ Million) Table 69. Global Antiemetics Revenue Market Share by Region (2021-2026) Table 70. Global Antiemetics Revenue Market Share by Region (2027-2032) Table 71. Johnson & Johnson Company Information Table 72. Johnson & Johnson Business Overview Table 73. Johnson & Johnson Antiemetics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Johnson & Johnson Antiemetics Product Portfolio Table 75. Johnson & Johnson Recent Development Table 76. Merck Company Information Table 77. Merck Business Overview Table 78. Merck Antiemetics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Merck Antiemetics Product Portfolio Table 80. Merck Recent Development Table 81. Eli Lilly Company Information Table 82. Eli Lilly Business Overview Table 83. Eli Lilly Antiemetics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Eli Lilly Antiemetics Product Portfolio Table 85. Eli Lilly Recent Development Table 86. Pfizer Company Information Table 87. Pfizer Business Overview Table 88. Pfizer Antiemetics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Pfizer Antiemetics Product Portfolio Table 90. Pfizer Recent Development Table 91. GlaxoSmithKline Company Information Table 92. GlaxoSmithKline Business Overview Table 93. GlaxoSmithKline Antiemetics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. GlaxoSmithKline Antiemetics Product Portfolio Table 95. GlaxoSmithKline Recent Development Table 96. Baxter Company Information Table 97. Baxter Business Overview Table 98. Baxter Antiemetics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Baxter Antiemetics Product Portfolio Table 100. Baxter Recent Development Table 101. Sanofi Aventis Company Information Table 102. Sanofi Aventis Business Overview Table 103. Sanofi Aventis Antiemetics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Sanofi Aventis Antiemetics Product Portfolio Table 105. Sanofi Aventis Recent Development Table 106. Bristol Myers Squibb Company Information Table 107. Bristol Myers Squibb Business Overview Table 108. Bristol Myers Squibb Antiemetics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Bristol Myers Squibb Antiemetics Product Portfolio Table 110. Bristol Myers Squibb Recent Development Table 111. Astellas Company Information Table 112. Astellas Business Overview Table 113. Astellas Antiemetics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Astellas Antiemetics Product Portfolio Table 115. Astellas Recent Development Table 116. Key Raw Materials Table 117. Raw Materials Key Suppliers Table 118. Antiemetics Distributors List Table 119. Antiemetics Customers List Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. Antiemetics Product Image Figure 2. Global Antiemetics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antiemetics Market Size (2021-2032) & (US$ Million) Figure 4. Global Antiemetics Sales (2021-2032) & (K Units) Figure 5. Global Antiemetics Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Antiemetics Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Steroids Image Figure 9. Antihistamines (H1 histamine receptor antagonists) Image Figure 10. Anticholinergics Image Figure 11. Dopamine antagonists Image Figure 12. Cannabinoids Image Figure 13. Benzodiazepines Image Figure 14. NK1 receptor antagonist Image Figure 15. 5-HT3 receptor antagonists Image Figure 16. Others Image Figure 17. Global Antiemetics Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 18. Global Antiemetics Sales Market Share 2021 VS 2025 VS 2032 Figure 19. Global Antiemetics Sales Market Share by Type (2021-2032) Figure 20. Global Antiemetics Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Antiemetics Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Antiemetics Revenue Market Share by Type (2021-2032) Figure 23. Retail Pharmacy Image Figure 24. Online Pharmacy Image Figure 25. Hospital Pharmacy Image Figure 26. Others Image Figure 27. Global Antiemetics Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global Antiemetics Sales Market Share 2021 VS 2025 VS 2032 Figure 29. Global Antiemetics Sales Market Share by Application (2021-2032) Figure 30. Global Antiemetics Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Antiemetics Revenue Market Share 2021 VS 2025 VS 2032 Figure 32. Global Antiemetics Revenue Market Share by Application (2021-2032) Figure 33. North America Antiemetics Sales and Growth Rate (2021-2032) & (K Units) Figure 34. North America Antiemetics Sales Market Share by Country (2021-2032) Figure 35. U.S. Antiemetics Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Canada Antiemetics Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Mexico Antiemetics Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Europe Antiemetics Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Europe Antiemetics Sales Market Share by Country (2021-2032) Figure 40. Germany Antiemetics Sales and Growth Rate (2021-2032) & (K Units) Figure 41. France Antiemetics Sales and Growth Rate (2021-2032) & (K Units) Figure 42. U.K. Antiemetics Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Italy Antiemetics Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Netherlands Antiemetics Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Asia Pacific Antiemetics Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Asia Pacific Antiemetics Sales Market Share by Country (2021-2032) Figure 47. China Antiemetics Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Japan Antiemetics Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Korea Antiemetics Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Southeast Asia Antiemetics Sales and Growth Rate (2021-2032) & (K Units) Figure 51. India Antiemetics Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Australia Antiemetics Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South America, Middle East and Africa Antiemetics Sales and Growth Rate (2021-2032) & (K Units) Figure 54. South America, Middle East and Africa Antiemetics Sales Market Share by Country (2021-2032) Figure 55. Brazil Antiemetics Sales and Growth Rate (2021-2032) & (K Units) Figure 56. South Africa Antiemetics Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Saudi Arabia Antiemetics Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Turkey Antiemetics Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Argentina Antiemetics Sales and Growth Rate (2021-2032) & (K Units) Figure 60. UAE Antiemetics Sales and Growth Rate (2021-2032) & (K Units) Figure 61. Egypt Antiemetics Sales and Growth Rate (2021-2032) & (K Units) Figure 62. Chile Antiemetics Sales and Growth Rate (2021-2032) & (K Units) Figure 63. Global Antiemetics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Global Antiemetics Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 65. North America Antiemetics Revenue (2021-2032) & (US$ Million) Figure 66. North America Antiemetics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Europe Antiemetics Revenue (2021-2032) & (US$ Million) Figure 68. Europe Antiemetics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Asia-Pacific Antiemetics Revenue (2021-2032) & (US$ Million) Figure 70. Asia-Pacific Antiemetics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 71. South America, Middle East and Africa Antiemetics Revenue (2021-2032) & (US$ Million) Figure 72. South America, Middle East and Africa Antiemetics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 73. Antiemetics Value Chain Figure 74. Manufacturing Cost Structure Figure 75. Antiemetics Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Years Considered Figure 79. Research Process Figure 80. Key Executives Interviewed

Scope & coverage.

Types
  • Steroids
  • Antihistamines (H1 histamine receptor antagonists)
  • Anticholinergics
  • Dopamine antagonists
  • Cannabinoids
  • Benzodiazepines
  • NK1 receptor antagonist
  • 5-HT3 receptor antagonists
  • Others
Applications
  • Retail Pharmacy
  • Online Pharmacy
  • Hospital Pharmacy
  • Others
Companies covered
  • Johnson & Johnson
  • Merck
  • Eli Lilly
  • Pfizer
  • GlaxoSmithKline
  • Baxter
  • Sanofi Aventis
  • Bristol Myers Squibb
  • Astellas

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Antiemetics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Antiemetics Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Antiemetics Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Antiemetics Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Antiemetics Market Dynamics
  1. 2.1 Antiemetics Industry Trends
  2. 2.2 Antiemetics Industry Drivers
  3. 2.3 Antiemetics Industry Opportunities and Challenges
  4. 2.4 Antiemetics Industry Restraints
3 Antiemetics Market by Manufacturers
  1. 3.1 Global Antiemetics Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Antiemetics Sales by Manufacturers (2021-2026)
  3. 3.3 Global Antiemetics Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Antiemetics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antiemetics Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Antiemetics Manufacturers, Product Type & Application
  7. 3.7 Global Antiemetics Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antiemetics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antiemetics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antiemetics Tier 1, Tier 2, and Tier 3
4 Antiemetics Market by Type
  1. 4.1 Antiemetics Type Introduction
  2. 4.1.1 Steroids
  3. 4.1.2 Antihistamines (H1 histamine receptor antagonists)
  4. 4.1.3 Anticholinergics
  5. 4.1.4 Dopamine antagonists
  6. 4.1.5 Cannabinoids
  7. 4.1.6 Benzodiazepines
  8. 4.1.7 NK1 receptor antagonist
  9. 4.1.8 5-HT3 receptor antagonists
  10. 4.1.9 Others
  11. 4.2 Global Antiemetics Sales by Type
  12. 4.2.1 Global Antiemetics Sales by Type (2021 VS 2025 VS 2032)
  13. 4.2.2 Global Antiemetics Sales by Type (2021-2032)
  14. 4.2.3 Global Antiemetics Sales Market Share by Type (2021-2032)
  15. 4.3 Global Antiemetics Revenue by Type
  16. 4.3.1 Global Antiemetics Revenue by Type (2021 VS 2025 VS 2032)
  17. 4.3.2 Global Antiemetics Revenue by Type (2021-2032)
  18. 4.3.3 Global Antiemetics Revenue Market Share by Type (2021-2032)
5 Antiemetics Market by Application
  1. 5.1 Antiemetics Application Introduction
  2. 5.1.1 Retail Pharmacy
  3. 5.1.2 Online Pharmacy
  4. 5.1.3 Hospital Pharmacy
  5. 5.1.4 Others
  6. 5.2 Global Antiemetics Sales by Application
  7. 5.2.1 Global Antiemetics Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Antiemetics Sales by Application (2021-2032)
  9. 5.2.3 Global Antiemetics Sales Market Share by Application (2021-2032)
  10. 5.3 Global Antiemetics Revenue by Application
  11. 5.3.1 Global Antiemetics Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Antiemetics Revenue by Application (2021-2032)
  13. 5.3.3 Global Antiemetics Revenue Market Share by Application (2021-2032)
6 Global Antiemetics Sales by Region
  1. 6.1 Global Antiemetics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antiemetics Sales by Region (2021-2032)
  3. 6.2.1 Global Antiemetics Sales by Region (2021-2026)
  4. 6.2.2 Global Antiemetics Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Antiemetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Antiemetics Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Antiemetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Antiemetics Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Antiemetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Antiemetics Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Antiemetics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Antiemetics Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Antiemetics Revenue by Region
  1. 7.1 Global Antiemetics Revenue by Region
  2. 7.1.1 Global Antiemetics Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Antiemetics Revenue by Region (2021-2026)
  4. 7.1.3 Global Antiemetics Revenue by Region (2027-2032)
  5. 7.1.4 Global Antiemetics Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Antiemetics Revenue (2021-2032)
  8. 7.2.2 North America Antiemetics Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Antiemetics Revenue (2021-2032)
  11. 7.3.2 Europe Antiemetics Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Antiemetics Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Antiemetics Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Antiemetics Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Antiemetics Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson & Johnson
  2. 8.1.1 Johnson & Johnson Company Information
  3. 8.1.2 Johnson & Johnson Business Overview
  4. 8.1.3 Johnson & Johnson Antiemetics Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Johnson & Johnson Antiemetics Product Portfolio
  6. 8.1.5 Johnson & Johnson Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Antiemetics Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck Antiemetics Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Eli Lilly
  14. 8.3.1 Eli Lilly Company Information
  15. 8.3.2 Eli Lilly Business Overview
  16. 8.3.3 Eli Lilly Antiemetics Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Eli Lilly Antiemetics Product Portfolio
  18. 8.3.5 Eli Lilly Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Antiemetics Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Antiemetics Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 GlaxoSmithKline
  26. 8.5.1 GlaxoSmithKline Company Information
  27. 8.5.2 GlaxoSmithKline Business Overview
  28. 8.5.3 GlaxoSmithKline Antiemetics Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GlaxoSmithKline Antiemetics Product Portfolio
  30. 8.5.5 GlaxoSmithKline Recent Developments
  31. 8.6 Baxter
  32. 8.6.1 Baxter Company Information
  33. 8.6.2 Baxter Business Overview
  34. 8.6.3 Baxter Antiemetics Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Baxter Antiemetics Product Portfolio
  36. 8.6.5 Baxter Recent Developments
  37. 8.7 Sanofi Aventis
  38. 8.7.1 Sanofi Aventis Company Information
  39. 8.7.2 Sanofi Aventis Business Overview
  40. 8.7.3 Sanofi Aventis Antiemetics Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sanofi Aventis Antiemetics Product Portfolio
  42. 8.7.5 Sanofi Aventis Recent Developments
  43. 8.8 Bristol Myers Squibb
  44. 8.8.1 Bristol Myers Squibb Company Information
  45. 8.8.2 Bristol Myers Squibb Business Overview
  46. 8.8.3 Bristol Myers Squibb Antiemetics Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bristol Myers Squibb Antiemetics Product Portfolio
  48. 8.8.5 Bristol Myers Squibb Recent Developments
  49. 8.9 Astellas
  50. 8.9.1 Astellas Company Information
  51. 8.9.2 Astellas Business Overview
  52. 8.9.3 Astellas Antiemetics Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Astellas Antiemetics Product Portfolio
  54. 8.9.5 Astellas Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Antiemetics Value Chain Analysis
  2. 9.1.1 Antiemetics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Antiemetics Production Mode & Process
  6. 9.2 Antiemetics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Antiemetics Distributors
  9. 9.2.3 Antiemetics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst